RYTM · US market
Rhythm Pharmaceuticals Inc
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$6.43bnFinancials dated 30 June 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- -US$210.22m
- Latest-quarter run-rate earnings
- -US$201.45m
- Latest fiscal-year earnings
- -US$201.92m
- Trailing revenue
- US$239.92m
- Latest-quarter run-rate revenue
- US$285.02m
- Latest fiscal-year revenue
- US$189.76m
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- MEDI · Harbor Health Care ETF3.79% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- XBI · State Street SPDR S&P Biotech ETF1.16% weight · Holdings dated 21 August 2026
- FSML · Franklin Small Cap Enhanced ETF1.03% weight · Holdings dated 30 June 2026
- RUDAX · BNY Mellon Small Cap Value Fund Class A0.92% weight · Holdings dated 30 June 2026
- LMOIX · ClearBridge Small Cap Growth Fund Class IS0.92% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- GURU · Global X Guru Index ETF0.88% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- MISCX · BNY Mellon Small Cap Multi-Strategy Fund Class Investor0.73% weight · Holdings dated 31 May 2026
- SHSSX · BlackRock Health Sciences Opportunities Portfolio Institutional Shares0.70% weight · Holdings dated 29 May 2026
- SSDZX · DWS Small Cap Growth Fund - Class R60.68% weight · Holdings dated 30 June 2026
- GDOC · Goldman Sachs Future Health Care Equity ETF0.68% weight · Holdings dated 31 May 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.